PROLYMPHOCYTIC LEUKEMIA
Clinical trials for PROLYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new PROLYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for PROLYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
New combo tested for relapsed leukemia: does adding rituximab help?
Disease control OngoingThis study tests whether adding rituximab to ibrutinib works better than ibrutinib alone for patients with chronic lymphocytic leukemia (CLL) that has returned after treatment. About 66 adults with relapsed CLL or related blood cancers will receive either ibrutinib alone or ibrut…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for tough blood cancers: targeted pill shows promise in advanced leukemia
Disease control OngoingThis study tests a daily pill called ibrutinib in 154 people with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or B-cell prolymphocytic leukemia (B-PLL) that has come back or stopped responding to other treatments. The goal is to see how well the drug con…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Kami Maddocks, MD • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New pill shows promise for controlling blood cancer
Disease control OngoingThis study tests a new drug called acalabrutinib for people with chronic lymphocytic leukemia (CLL) or related blood cancers. The goal is to see if the drug is safe and can shrink or control the cancer. Participants take the drug by mouth, and the study tracks side effects and ho…
Matched conditions: PROLYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 11, 2026 20:38 UTC